Total Payments
$14,293
2024 Payments
$3,096
Companies
44
Transactions
614
Medicare Patients
11,410
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$12,547 (87.8%)
Travel$1,551 (10.8%)
Education$195.53 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,547 | 605 | 87.8% |
| Travel and Lodging | $1,551 | 6 | 10.8% |
| Education | $195.53 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,337 | 189 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,929 | 91 | $0 (2024) |
| Pulmonx Corporation | $1,181 | 5 | $0 (2024) |
| Veran Medical Technologies, Inc. | $720.36 | 3 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $705.73 | 28 | $0 (2024) |
| Insmed, Inc. | $610.69 | 21 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $425.42 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $424.99 | 23 | $0 (2024) |
| Mylan Specialty L.P. | $419.80 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $407.93 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,096 | 118 | GlaxoSmithKline, LLC. ($499.08) |
| 2023 | $2,300 | 92 | Pulmonx Corporation ($537.60) |
| 2022 | $2,018 | 76 | AstraZeneca Pharmaceuticals LP ($452.03) |
| 2021 | $1,434 | 71 | GlaxoSmithKline, LLC. ($430.15) |
| 2020 | $1,237 | 57 | GlaxoSmithKline, LLC. ($395.87) |
| 2019 | $2,178 | 79 | Veran Medical Technologies, Inc. ($720.36) |
| 2018 | $1,077 | 66 | GlaxoSmithKline, LLC. ($267.88) |
| 2017 | $952.38 | 55 | GlaxoSmithKline, LLC. ($334.51) |
All Payment Transactions
614 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/11/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Immunology and Neurology | ||||||
| 11/08/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $209.06 | General |
| Category: SURGERY | ||||||
| 11/07/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: SURGERY | ||||||
| 11/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.86 | General |
| Category: Immunology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 10/16/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,786 | 3,819 | $651,553 | $235,398 |
| 2022 | 23 | 2,599 | 3,946 | $689,041 | $243,738 |
| 2021 | 22 | 2,751 | 4,712 | $886,311 | $314,736 |
| 2020 | 27 | 3,274 | 5,104 | $1.0M | $368,638 |
Total Patients
11,410
Total Services
17,581
Medicare Billing
$1.2M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 417 | 595 | $133,875 | $53,496 | 40.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 215 | 637 | $89,180 | $38,318 | 43.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 299 | $59,501 | $27,562 | 46.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 461 | 520 | $77,670 | $20,491 | 26.4% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 249 | 289 | $43,800 | $16,932 | 38.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 112 | 115 | $37,950 | $15,197 | 40.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 72 | 72 | $30,240 | $11,666 | 38.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 465 | 524 | $49,670 | $10,015 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $29,040 | $9,733 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 65 | $19,435 | $8,294 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 84 | $15,120 | $5,162 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 42 | $10,500 | $4,199 | 40.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 120 | 124 | $11,780 | $2,957 | 25.1% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 20 | 20 | $9,000 | $2,146 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $6,102 | $2,054 | 33.7% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 12 | 12 | $4,800 | $1,978 | 41.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 33 | $3,300 | $1,281 | 38.8% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 25 | 30 | $2,850 | $823.20 | 28.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 16 | 16 | $6,400 | $779.65 | 12.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 32 | 46 | $1,380 | $654.58 | 47.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 55 | 55 | $2,200 | $378.40 | 17.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 56 | 57 | $2,280 | $355.04 | 15.6% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 28 | 28 | $1,400 | $331.02 | 23.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 13 | 13 | $2,340 | $326.89 | 14.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 16 | 16 | $1,440 | $157.12 | 10.9% |
About Dr. Varsha Kulkarni, M.D
Dr. Varsha Kulkarni, M.D is a Critical Care Medicine healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366528333.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Varsha Kulkarni, M.D has received a total of $14,293 in payments from pharmaceutical and medical device companies, with $3,096 received in 2024. These payments were reported across 614 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($12,547).
As a Medicare-enrolled provider, Kulkarni has provided services to 11,410 Medicare beneficiaries, totaling 17,581 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Augusta, GA
- Active Since 10/31/2006
- Last Updated 07/31/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1366528333
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,282
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $978.36
- NUCALA (Biological) $809.91
- Spin (Device) $720.36
- FASENRA (Biological) $694.90
- DUPIXENT (Biological) $596.12
- Arikayce (Drug) $504.31
- Da Vinci Surgical System (Device) $425.42
- UPTRAVI (Drug) $407.85
- Adempas (Drug) $376.97
- TEZSPIRE (Biological) $375.17
- ANORO (Drug) $372.84
- OPSUMIT (Drug) $297.88
- AREXVY (Drug) $279.20
- ACTHAR (Biological) $274.76
- BREZTRI (Drug) $259.42
- TYVASO (Drug) $240.25
- SYMBICORT (Drug) $230.79
- YUPELRI (Drug) $220.66
- OFEV (Drug) $204.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Augusta
Bruce Friedman, M.d, M.D
Critical Care Medicine — Payments: $1.0M
Critical Care Medicine $1.0M
Dr. Carmel Joseph, Md, MD
Critical Care Medicine — Payments: $44,125
Critical Care Medicine $44,125
Shaheen Islam, Mbbs, MBBS
Critical Care Medicine — Payments: $21,874
Critical Care Medicine $21,874
Dr. Scott Pethke, M.d, M.D
Critical Care Medicine — Payments: $14,046
Critical Care Medicine $14,046
Brent Bermingham, Md, MD
Critical Care Medicine — Payments: $5,374
Critical Care Medicine $5,374
Dr. Anthony Ramage, Do, DO
Critical Care Medicine — Payments: $2,621
Critical Care Medicine $2,621